MustGrow Biologics completes successful first third-party production run for mustard plant extract | News Direct

MustGrow Biologics completes successful first third-party production run for mustard plant extract

News release by MustGrow Biologics Corp.

facebook icon linkedin icon twitter icon pinterest icon email icon Toronto | June 13, 2023 02:05 PM Eastern Daylight Time

 

MustGrow Biologics President and CEO Corey Giasson joins Natalie Stoberman from the Proactive newsrooms to share the company's successful completion of initial commercial run-rate production via a third-party contract manufacturer for its mustard plant-based extract.

Giasson says this production milestone demonstrates the scalability of its product process along with positioning the company for future sales and commercialization. Giasson adds that this milestone validates MustGrow's strategy and reducing the need for significant upfront investment to begin the mass commercialization process. Using a third-party manufacturer enables a low risk and scalable foundation for their production process, Giasson said.

 

Contact Details

 

Proactive Canada

 

+1 604-688-8158

 

na-editorial@proactiveinvestors.com

Tags

ProactiveInvestorsMustGrowBiologicsBiotechCompanyProductionMilestoneMustardPlantExtractCommercialProductionScalabilityProductProcessFutureSalesCommercializationCEOStrategyValidationLowRiskMassCommercializationGlobalExpansionContractManufacturersinvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews